The Stock Exchange of Thailand 1. Analysis of Overall Operating Results and Financial Position of the Company and its subsidiary 1.1 Analysis of Overall Operating Results for the Company and its

Summary Significant Event Operating Highlights in Q2/2024 Q2/23 Q2/24 Change +/(-) 1H/23 1H/24 Change +/(-) (THB million) %YoY %YoY Operating Revenue 299 376 26% 563 716 27% Gross Profit 192 250 30% 361 476

to a 20% reduction in IVL’s core EBITDA. Operating cash flow through this period increased by 33% to $1.3B, as a result of lower prices and operational excellence. IVL has proposed a dividend of

@kiatnakin.co.th Tel. +66-2495-1366 Website: www.kiatnakin.co.th http://www.kiatnakin.co.th/ 2 Management Discussion and Analysis (MD&A) For the second quarter and six-month ended June 30, 2019 comparing operating

-2495-1366 Website: www.kiatnakin.co.th http://www.kiatnakin.co.th/ 2 Management Discussion and Analysis (MD&A) For the second quarter and six-month ended June 30, 2019 comparing operating performance and

operating performance and financial position for the third quarter and nine-month ended September 30, 2019 with those of 2018. This report discusses principal changes in the unreviewed consolidated financial

. +66-2495-1366 Website: www.kiatnakin.co.th http://www.kiatnakin.co.th/ 2 Management Discussion and Analysis (MD&A) For the third quarter and nine-month ended September 30, 2019 comparing operating

from rental and rendering of services from new rental spaces and improved occupancy rates, and decreased selling and distribution expenses from improved cost management • Operating revenue increased by

trade and other payables. The total shareholders’ equity amounted to 3,6 6 7 .0 6 million baht, increased by 70.76 million baht. This represented the Company’s book value per share at 18.34 and D/E ratio

Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company